Rolando Gutiérrez-Esteinou

2021

In 2021, Rolando Gutiérrez-Esteinou earned a total compensation of $11.4M as Chief Medical Officer at ATAI Life Sciences N.V..

Compensation breakdown

Bonus$195,378
Option Awards$10,753,988
Salary$420,000
Total$11,369,366

Gutiérrez-Esteinou received $10.8M in option awards, accounting for 95% of the total pay in 2021.

Gutiérrez-Esteinou also received $195.4K in bonus and $420K in salary.

Rankings

In 2021, Rolando Gutiérrez-Esteinou's compensation ranked 852nd out of 12,415 executives tracked by ExecPay. In other words, Gutiérrez-Esteinou earned more than 93.1% of executives.

ClassificationRankingPercentile
All
852
out of 12,415
93rd
Division
Manufacturing
278
out of 5,505
95th
Major group
Chemicals And Allied Products
93
out of 2,375
96th
Industry group
Drugs
78
out of 2,096
96th
Industry
Pharmaceutical Preparations
50
out of 1,546
97th
Source: SEC filing on September 19, 2022.

Gutiérrez-Esteinou's colleagues

We found two more compensation records of executives who worked with Rolando Gutiérrez-Esteinou at ATAI Life Sciences N.V. in 2021.

2021

Florian Brand

ATAI Life Sciences N.V.

Chief Executive Officer

2021

Srinivas Rao

ATAI Life Sciences N.V.

Chief Scientific Officer

News

In-depth

You may also like